The Drug Control Group (DG n=30) follows the conventional drug treatment for TMJDs related pain, 2 non‐consecutive cycles of 5 days of nimesulide (100mg a day), interspersed with one 5 days cycle of cyclobenzaprine hydrochloride (10 mg a day) Two pain evaluation are registered, before and after treatment.